Onderneming Jupiter Neurosciences, Inc.
Aandelen
JUNS
US48208B2034
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 5
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alexander Rosén
FOU | Founder | 33 | 01-06-15 |
Marshall Hayward
FOU | Founder | 69 | 01-06-15 |
Christer Rosén
CEO | Chief Executive Officer | 72 | 01-06-15 |
Alison D. Silva
PSD | President | 46 | 01-01-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Christer Rosén
CEO | Chief Executive Officer | 72 | 01-06-15 |
Marshall Hayward
FOU | Founder | 69 | 01-06-15 |
Director/Board Member | 42 | 08-09-21 | |
John Ditton
BRD | Director/Board Member | 60 | 08-09-21 |
Alison D. Silva
PSD | President | 46 | 01-01-18 |
Holger Weis
BRD | Director/Board Member | 61 | 08-09-21 |
Julie Kampf
BRD | Director/Board Member | 62 | 08-09-21 |
Allison W. Brady
BRD | Director/Board Member | 53 | 08-09-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 16 409 935 | 1 331 486 ( 8,114 %) | 0 | 8,114 % |
Bedrijfsgegevens
Jupiter Neurosciences, Inc.
1001 North US Highway 1 Suite 504
33477, Jupiter
+
http://www.jupiterneurosciences.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+55,70% | 59,34 mld. | |
+42,83% | 40,24 mld. | |
-5,39% | 39,88 mld. | |
-5,56% | 28,55 mld. | |
+16,46% | 27,26 mld. | |
-20,56% | 19,23 mld. | |
+33,03% | 12,61 mld. | |
+25,85% | 12,28 mld. | |
+2,72% | 12,49 mld. |